CanaDan Bio ApS: Financial statements 2021
CVR: 40896813
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CanaDan Bio ApS (CVR 40896813) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -47,202 and a net result of DKK -10,711 compared with DKK -23,996 the year before. Equity in the 2021 report amounted to DKK 5,284. The solvency ratio was 1.1%.
- Revenue
- DKK 0
- Gross Profit
- DKK -47,202
- Profit/Loss
- DKK -10,711
- Equity
- DKK 5,284
- Total Assets
- DKK 492,559
Official annual report
Find more companies like CanaDan Bio ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
CanaDan Bio ApS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -23,996.
About CanaDan Bio ApS
CanaDan Bio ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Lionel le Lay. The company is owned by PYTHOR ApS and Megapol ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,395 and a net result of DKK 4,372 compared with DKK 3,483 the year before. Equity in the 2025 report amounted to DKK 28,083.